These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 16741250

  • 1. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
    Dicker F, Kater AP, Prada CE, Fukuda T, Castro JE, Sun G, Wang JY, Kipps TJ.
    Blood; 2006 Nov 15; 108(10):3450-7. PubMed ID: 16741250
    [Abstract] [Full Text] [Related]

  • 2. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
    Lapalombella R, Andritsos L, Liu Q, May SE, Browning R, Pham LV, Blum KA, Blum W, Ramanunni A, Raymond CA, Smith LL, Lehman A, Mo X, Jarjoura D, Chen CS, Ford R, Rader C, Muthusamy N, Johnson AJ, Byrd JC.
    Blood; 2010 Apr 01; 115(13):2619-29. PubMed ID: 19965642
    [Abstract] [Full Text] [Related]

  • 3. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH, Mulkens CE, van Laar J, Derks IA, Suo G, Croon-de Boer F, van Oers MH, Eldering E, Wang JY, Kater AP.
    Leuk Lymphoma; 2015 Apr 01; 56(8):2439-47. PubMed ID: 25511680
    [Abstract] [Full Text] [Related]

  • 4. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.
    Kater AP, Dicker F, Mangiola M, Welsh K, Houghten R, Ostresh J, Nefzi A, Reed JC, Pinilla C, Kipps TJ.
    Blood; 2005 Sep 01; 106(5):1742-8. PubMed ID: 15914559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.
    Wierda WG, Castro JE, Aguillon R, Sampath D, Jalayer A, McMannis J, Prussak CE, Keating M, Kipps TJ.
    Leukemia; 2010 Nov 01; 24(11):1893-900. PubMed ID: 20882050
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.
    Alonso R, López-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E, Colomer D.
    Blood; 2009 Aug 20; 114(8):1563-75. PubMed ID: 19541822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference.
    Castro JE, Prada CE, Aguillon RA, Kitada S, Fukuda T, Motta M, Wu C, Dicker F, Sun G, Wang JY, Carson DA, Reed JC, Kipps TJ.
    Leukemia; 2006 Apr 20; 20(4):680-8. PubMed ID: 16498393
    [Abstract] [Full Text] [Related]

  • 12. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.
    Hallaert DY, Jaspers A, van Noesel CJ, van Oers MH, Kater AP, Eldering E.
    Blood; 2008 Dec 15; 112(13):5141-9. PubMed ID: 18796631
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells.
    Allen JC, Talab F, Zuzel M, Lin K, Slupsky JR.
    Blood; 2011 Feb 24; 117(8):2414-22. PubMed ID: 21220745
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
    Tiwary R, Yu W, Sanders BG, Kline K.
    Breast Cancer Res; 2011 Jan 07; 13(1):R1. PubMed ID: 21214929
    [Abstract] [Full Text] [Related]

  • 17. The course of etoposide-induced apoptosis in Jurkat cells lacking p53 and Bax.
    Karpinich NO, Tafani M, Schneider T, Russo MA, Farber JL.
    J Cell Physiol; 2006 Jul 07; 208(1):55-63. PubMed ID: 16547931
    [Abstract] [Full Text] [Related]

  • 18. c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells.
    Thottassery JV, Westbrook L, Someya H, Parker WB.
    Mol Cancer Ther; 2006 Feb 07; 5(2):400-10. PubMed ID: 16505115
    [Abstract] [Full Text] [Related]

  • 19. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
    Furman RR, Asgary Z, Mascarenhas JO, Liou HC, Schattner EJ.
    J Immunol; 2000 Feb 15; 164(4):2200-6. PubMed ID: 10657675
    [Abstract] [Full Text] [Related]

  • 20. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
    Tromp JM, Geest CR, Breij EC, Elias JA, van Laar J, Luijks DM, Kater AP, Beaumont T, van Oers MH, Eldering E.
    Clin Cancer Res; 2012 Jan 15; 18(2):487-98. PubMed ID: 22128299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.